Amedisys Inc (AMED)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 496,935 | 388,961 | 356,684 | 361,984 | 350,554 |
| Total current liabilities | US$ in thousands | 473,721 | 355,529 | 374,282 | 456,337 | 326,943 |
| Current ratio | 1.05 | 1.09 | 0.95 | 0.79 | 1.07 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $496,935K ÷ $473,721K
= 1.05
The current ratio for Amedisys Inc. has fluctuated over the past five years. As of December 31, 2023, the current ratio stands at 1.05, which is slightly lower than the previous year's ratio of 1.09. This indicates that the company may have slightly less short-term assets relative to its short-term liabilities compared to the previous year.
Looking further back, the current ratio was 0.95 in 2021, 0.79 in 2020, and 1.07 in 2019. The significant increase in the current ratio from 2020 to 2021 suggests an improvement in the company's liquidity position, although the ratio dropped in 2022 and 2023.
Overall, the current ratio for Amedisys Inc. has shown some variability in recent years, with the company's ability to meet its short-term obligations differing annually. It is essential for stakeholders to monitor this ratio closely to assess the company's liquidity and short-term financial health.
Peer comparison
Dec 31, 2023